Avoro Capital Advisors LLC Pacira Bio Sciences, Inc. Transaction History

Avoro Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $58.1 Million - $74.9 Million	-1,600,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $42.8 Million - $54 Million	1,200,000 Added 300.0%	1,600,000 $60.9 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $545,126 - $688,303	-13,196 Reduced 3.19%	400,000 $17.2 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $34.4 Million - $54.5 Million	-1,047,414 Reduced 71.71%	413,196 $20.3 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $7 Million - $10.1 Million	-254,462 Reduced 14.84%	1,460,610 $46.8 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $26 Million - $40.2 Million	866,500 Added 102.11%	1,715,072 $53.4 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $14.7 Million - $21.7 Million	-462,888 Reduced 35.3%	848,572 $38.7 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $46.8 Million - $51.8 Million	1,311,460	1,311,460 $49.2 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.